Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study

• Main Authors: Magnelis Machado-Leiva (Author), Daise Jiménez-Rodríguez (Author), Tatiana Festary-Casanovas (Author), Deydree C. Silveira-Pacheco (Author), Emilio S. Barroso-de la Cruz (Author), Mariela Suárez-Reyes (Author), Genma Salas-Cruz (Author), Haydee Wong-Arocha (Author), Roberto Fernández-Viera (Author), Ángela D. Tuero-Iglesias (Author), René Delgado-Hernández (Author), Idrian García-García (Author), Calprost Study Group (Author)
• Format: Book
• Published: GarVal Editorial Ltda., 2016-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context: Benign Prostatic Hyperplasia (BPH) is a common disease that course with Lower Urinary Tract Symptoms (LUTS), mainly in over 50 years-old men. Commonly indicated drugs such as alpha adrenergic-blockers are life-treatment with some adverse reactions. Center for Drug Research and Development p...